There has been a resurgence of measles cases in the USA and Europe, including in individuals vaccinated with two doses of the vaccine. - GreenMedInfo Summary
Variability in Humoral Immunity to Measles Vaccine: New Developments.
Trends Mol Med. 2015 Dec ;21(12):789-801. Epub 2015 Nov 18. PMID: 26602762
Iana H Haralambieva
Despite the existence of an effective measles vaccine, resurgence in measles cases in the USA and across Europe has occurred, including in individuals vaccinated with two doses of the vaccine. Host genetic factors result in inter-individual variation in measles vaccine-induced antibodies, and play a role in vaccine failure. Studies have identified HLA (human leukocyte antigen) and non-HLA genetic influences that individually or jointly contribute to the observed variability in the humoral response to vaccination among healthy individuals. In this exciting era, new high-dimensional approaches and techniques including vaccinomics, systems biology, GWAS, epitope prediction and sophisticated bioinformatics/statistical algorithms provide powerful tools to investigate immune response mechanisms to the measles vaccine. These might predict, on an individual basis, outcomes of acquired immunity post measles vaccination.